- Tytuł:
- Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
- Autorzy:
- Źródło:
- Clinical Breast Cancer; Feb2018, Vol. 18 Issue 1, p88-94, 7p
Czasopismo naukowe